Global Breast Imaging Market 2019-2023: Ionizing Breast Imaging Segment is Expected to Account for the Largest Market Share

News provided by

Jan 31, 2019, 12:00 ET

DUBLIN, Jan. 31, 2019 /PRNewswire/ --

The "Breast Imaging Market by Technology (Ionizing (Mammography (Digital Mammography, 3D Mammogram, Analog), MBI, PET-CT, PEM), Non-ionizing (Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering

The global breast imaging market is projected to reach USD 4.6 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 8.0%.

Growth in this market is largely driven by factors such as the rising prevalence of breast cancer, growth in the geriatric population (as age contributes to the risk of breast cancer) and changing lifestyles, which have increased the overall possibility of cancer occurrence.

However, errors in screening and misdiagnosis, the side-effects of radiation exposure, and the growing adoption of refurbished imaging systems are the major factors that are expected to restrain the growth of this market during the forecast period.

The ionizing breast imaging segment is expected to account for the largest market share during the forecast period

Based on technology, the breast imaging market is segmented into ionizing (mammography, PET-CT, MBI, and PEM), non-ionizing (breast ultrasound, breast MRI, AWBU, and breast thermography), and other breast imaging technologies (CBCT, electrical impedance tomography, and optical imaging). The ionizing breast imaging segment accounted for the largest share of this market in 2018, driven by the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.

The molecular breast imaging (MBI) segment to witness second-highest growth in the ionizing breast imaging market during the forecast period

Based on type, the ionizing breast imaging technology market is segmented into mammography, PET-CT, MBI, and PEM. The MBI segment is expected to witness the second-highest growth rate in the market during the forecast period. The MBI technique is simple, fast, and highly sensitive and can be used for patients who are claustrophobic or allergic to gadolinium, which are the key factors driving its adoption in the breast imaging market.

Europe to account for the second-largest share of the global market in 2018

The breast imaging market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe accounted for the second-largest share of the global breast imaging market in 2018. The increasing number of regulatory approvals for advanced breast imaging modalities, growing number of distribution collaborations and partnerships among market players, and the implementation of various awareness programs by several European organizations are the major factors propelling the demand for breast imaging in Europe.

As of 2017, Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), and Philips Healthcare (Netherlands) were the leading companies in the market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Breast Imaging: Market Overview
4.2 Technology Analysis - Breast Imaging Market, By Region
4.3 Asia Pacific Mammography Market, By Type and Country
4.4 European Ionizing Breast Imaging Market, By Type and Country
4.5 Non-Ionizing Breast Imaging Market, By Type
4.6 Geographic Snapshot of the Breast Imaging Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Incidence of Breast Cancer
5.2.1.2 Increasing Public-Private Investments, Funds, and Grants
5.2.1.3 Increasing Awareness on Early Detection of Breast Cancer
5.2.1.4 Growth in the Aging Population
5.2.2 Restraints
5.2.2.1 High Cost of Breast Imaging Systems
5.2.2.2 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Emerging Economies Offer High Growth Potential
5.2.3.2 Miniaturization and Technological Advancements
5.2.4 Challenges
5.2.4.1 Side-Effects of Radiation Exposure
5.2.4.2 Errors in Breast Cancer Screening and Diagnosis
5.2.4.3 Risk of Overdiagnosis and Patient Anxiety
5.2.4.4 Increasing Adoption of Refurbished Imaging Systems
5.3 Market Trends
5.3.1 Artificial Intelligence
5.3.2 Personalized Approach to Breast Cancer Screening
5.4 Screening Guidelines for Breast Cancer
5.5 Pricing Analysis

6 Breast Imaging Market, By Technology
6.1 Introduction
6.2 Ionizing Breast Imaging Technologies
6.2.1 Mammography
6.2.1.1 Full-Field Digital Mammography
6.2.1.1.1 Ffdm Offers Significant Advantages Over Conventional Analog Mammography, Such as the Use of Lower Radiation Doses and Reduced Breast Compression Pressure
6.2.1.2 Analog Mammography
6.2.1.2.1 Superior Accuracy and Efficiency Offered By Digital Mammography Systems Have Limited the Adoption of Analog Mammography System
6.2.1.3 3d Breast Tomosynthesis
6.2.1.3.1 3d Breast Tomosynthesis Segment to Witness the Highest Growth Rate in the Mammography Market During the Forecast Period
6.2.2 Positron Emission Tomography-Computed Tomography (Pet-Ct)
6.2.2.1 Combined Scans From Pet and Ct Provide A More Accurate Diagnosis as Compared to the Individual Scans Performed
6.2.3 Molecular Breast Imaging
6.2.3.1 Mbi Technique is Simple, Fast, and Highly Sensitive and Can Be Used for Patients Who are Claustrophobic Or Allergic to Gadolinium
6.2.4 Positron Emission Mammography
6.2.4.1 Pem Involves Radiation Exposure Throughout the Body, Which Increases the Risk of CancerA Major Disadvantage Associated With This Technique
6.3 Non-Ionizing Breast Imaging Technologies
6.3.1 Breast Ultrasound
6.3.1.1 Lower Cost, Increasing Awareness, and Easy Availability of Ultrasound Devices for Breast Imaging are Driving the Growth of This Market
6.3.2 Breast MRI
6.3.2.1 Technological Advancements in Breast MRI and the Rising Demand for Technologies That Involve Minimal Use of Radiation are the Key Factors Driving the Growth of This Market
6.3.3 Automated Whole-Breast Ultrasound
6.3.3.1 Awbu Helps Spot Tiny Cancers in the Mammogram of the Fatty Breast
6.3.4 Breast Thermography
6.3.4.1 This Technique is Not Effective When Used as A Standalone Test for Breast Cancer Screening
6.4 Other Breast Imaging Technologies
6.4.1 Optical Imaging
6.4.2 Cone-Beam Computed Tomography
6.4.3 Electric Impedance Tomography
6.5 Cad Software

7 Breast Imaging Market, By Region
7.1 Introduction
7.2 North America
7.2.1 US
7.2.1.1 US to Dominate the North American Breast Imaging Market
7.2.2 Canada
7.2.2.1 Increasing Incidence of Breast Cancer and Government Initiatives for Breast Cancer Awareness to Drive Market Growth in Canada
7.3 Europe
7.3.1 Germany
7.3.1.1 Wider Acceptance of Both Ionizing and Non-Ionizing Breast Imaging Technologies and the Rising Demand for Improved Diagnostics are the Major Factors Driving Market Growth in Germany
7.3.2 France
7.3.2.1 Rapidly Increasing Aging Population and the High Incidence of Breast Cancer are Driving the Adoption of Breast Imaging Technologies in France
7.3.3 UK
7.3.3.1 High Breast Cancer Incidence Rate and Public-Private Initiatives to Spread Awareness About Early Breast Cancer Detection and Screening to Drive Market Growth
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.1.1 Growing Geriatric Population and Presence of A Universal Healthcare Reimbursement Scenario to Boost the Adoption of Breast Imaging Procedures in Japan
7.4.2 China
7.4.2.1 Increasing Incidence of Breast Cancer and Growing Patient Population in China to Drive the Demand for Breast Imaging in the Country
7.4.3 India
7.4.3.1 Government Initiatives to Improve Female Health to Drive Market Growth in India
7.4.4 Rest of APAC
7.5 Rest of the World
7.5.1 Latin America
7.5.1.1 Latin America to Account for the Largest Share of the RoW Breast Imaging Market in 2018
7.5.2 Middle East & Africa
7.5.2.1 Improving Healthcare Infrastructure and Increasing Public-Private Investments to Drive Market Growth in the Me&A Region

8 Competitive Landscape
8.1 Introduction
8.2 Competitive Leadership Mapping (Overall Market)
8.3 Vendor Inclusion Criteria
8.4 Vendor Dive
8.5 Competitive Leadership Mapping (Smse/Start-Up)
8.6 Market Share Analysis, By Modality
8.7 Competitive Scenario

9 Company Profiles

Aurora Imaging Technology, Inc.
Canon Inc.
Cmr Naviscan
Delphinus Medical Technologies, Inc.
Dilon Technologies, Inc.
Fujifilm Holdings Corporation
GE Healthcare (A Part of General Electric Company)
Hologic, Inc.
Kub Technologies
Micrima Limited
Philips Healthcare (A Part of Koninklijke Philips N.V.)
Planmed Oy
Siemens Healthineers (A Part of Siemens AG)
Sonocin, Inc.
Supersonic Imagine

For more information about this report visit https://www.researchandmarkets.com/research/4cfnwl/global_breast?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets